We are live on
!
Find out more
MPM
Meritage Portfolio Management Portfolio holdings
AUM
$1.51B
Turnover
12.14%
1-Year Est. Return
26.61%
This Fund
S&P 500
This Quarter
Est. Return
+8.47%
1 Year Est. Return
+26.61%
3 Year Est. Return
+97.45%
5 Year Est. Return
+138.05%
10 Year Est. Return
+560.46%
AUM
$1.66B
AUM Growth
+$158M
(+11%)
Cap. Flow
+$44.7M
Cap. Flow
% of AUM
2.69%
Top 10 Holdings %
Top 10 Hldgs %
28.07%
Holding
333
New
46
Increased
145
Reduced
75
Closed
31
Avg Time Held
1.9
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sage Therapeutics
SAGE
|
+$19.2M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$15.2M |
| 3 |
Dropbox
DBX
|
+$11.9M |
| 4 |
T. Rowe Price
TROW
|
+$11.2M |
| 5 |
MKS Inc
MKSI
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thor Industries
THO
|
+$14.8M |
| 2 |
Rockwell Automation
ROK
|
+$11.2M |
| 3 |
Johnson & Johnson
JNJ
|
+$10.1M |
| 4 |
IPHI
INPHI CORPORATION
IPHI
|
+$9.31M |
| 5 |
Take-Two Interactive
TTWO
|
+$9.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Miscellaneous | 14.56% |
| 3 | Consumer Discretionary | 12.59% |
| 4 | Industrials | 9.66% |
| 5 | Healthcare | 9.49% |
Similar funds
NAS
JCM
LGWM
APW
CB
CGL
QLSGSCF
A
Meritage Portfolio Management's Q2 2021 Portfolio in Review
As of Q2 2021, Meritage Portfolio Management held 333 positions worth $1.66B, up 11% from $1.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Meritage Portfolio Management's Q2 2021 filing shows 46 new, 145 increased, 75 reduced and 31 closed positions. Its largest new stake was Sage Therapeutics: 272,192 shares worth $15.5M. The largest sale was Thor Industries, an estimated $14.8M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
- Meritage Portfolio Management's largest Q2 2021 buy was Sage Therapeutics: 272,192 shares worth $15.5M.
- Meritage Portfolio Management added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $15.2M increase.
- Meritage Portfolio Management's biggest Q2 2021 reduction was Johnson & Johnson, cutting an estimated $10.1M.
- Meritage Portfolio Management fully exited Thor Industries in Q2 2021, selling an estimated $14.8M.
- Meritage Portfolio Management's ten largest holdings make up 28% of its $1.66B portfolio in Q2 2021.
- Meritage Portfolio Management opened 46 new positions and closed 31 in Q2 2021.
- Meritage Portfolio Management's portfolio value rose 11% quarter-over-quarter to $1.66B.
Based on Meritage Portfolio Management's 13F filing for Q2 2021, filed 26 Jul 2021.